Edward Daeyoung Youn, DPM
Podiatry · Antioch
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
Offices
6 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Alta Bates Summit Medical Center - Alta Bates Camp · Sutter Delta Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Youn’s office to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- Sutter Delta Medical CenterAntioch, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.173, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Sutter Delta Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.173 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.03) · 561 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.47 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 176.46 (114.75 to 238.17) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 113 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.3 · 260 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.5 · 56 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 1,274 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 3,285 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 3,374 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.47 (1.02 to 5.93) · 364 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.16 (0.49 to 3.83) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.63 (0 to 18.4) · 26 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.2 to 3.22) · 81 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.24 (0 to 1.07) · 2,713 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.962 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 116 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 316 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 20 · 83 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 7.1 · 298 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 27.3 · 269 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 283 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.7 to 17.1) · 529 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 45 cases | No different | Jan 2024 – Dec 2024 |
What patients said (610 patients answered, 13% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 70% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 60% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 64% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$88,620
Medicare paid this office $88,620 for 404 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 99 | $17,295 | $114 |
| Short return visit (20+ min) | 152 | $15,918 | $77 |
| New patient visit (30+ min) | 123 | $11,935 | $97 |
| New patient visit (45+ min) | 73 | $10,209 | $140 |
| Removal of fingernails or toenails, 6 or more nails | 111 | $8,558 | $40 |
See all 12 services
| Return visit (30+ min) | 99 | $17,295 | $114 |
| Short return visit (20+ min) | 152 | $15,918 | $77 |
| New patient visit (30+ min) | 123 | $11,935 | $97 |
| New patient visit (45+ min) | 73 | $10,209 | $140 |
| Removal of fingernails or toenails, 6 or more nails | 111 | $8,558 | $40 |
| Removal of skin and tissue, 20.0 sq cm or less | 13 | $4,269 | $126 |
| Removal of noncancer thickened skin growth, 1 growth | 31 | $4,041 | $68 |
| Permanent removal fingernail or toenail | 16 | $2,848 | $158 |
| Removal of noncancer thickened skin growth, 2-4 growths | 19 | $2,474 | $77 |
| Removal of fingernails or toenails, 1-5 nails | 30 | $1,103 | $32 |
| Injection into tendon or ligament | 11 | $863 | $48 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 24 | $26 | None |
Procedures Medicare counted
| Removal of nail tissue | 341 | More than 79% of doctors who do this |
| Removal of skin lesions | 12 | More than 59% of doctors who do this |
| Removal of tissue | 65 | More than 81% of doctors who do this |
| Removal or shaving of skin growth | 134 | More than 87% of doctors who do this |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
404 Original Medicare patients in 2024. Average age 73 · Under 65 11% · 85 and older 13% · Women 64% · Also on Medicaid 27% · Health risk score 1.38. At or below the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 70% · Diabetes 35% · Chronic kidney disease 24% · Coronary heart disease 22% · Depression 18% · Heart failure 17% · Atrial fibrillation 15% · COPD 14% · Cancer 13% · Dementia 9% · Stroke 7%.
The office billed $357,121, Medicare allowed $120,678 and paid $88,620; for 1,070 services of 45 kinds; $26 of it was for drugs given in the office and $88,594 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 404 | 1,070 | 73 | 1.38 | $357,121 | $88,620 |
| 2023 | 354 | 1,000 | 73 | 1.43 | $365,329 | $90,422 |
| 2022 | 358 | 1,031 | 74 | 1.43 | $342,820 | $87,527 |
| 2021 | 457 | 1,244 | 74 | 1.55 | $370,545 | $97,960 |
| 2020 | 273 | 937 | 74 | 1.73 | $290,461 | $70,936 |
| 2019 | 168 | 561 | 71 | 2.10 | $171,039 | $51,515 |
| 2018 | 59 | 1,165 | 67 | 3.56 | $262,087 | $95,341 |
| 2017 | 290 | 1,417 | 71 | 2.75 | $266,094 | $79,235 |
| 2016 | 107 | 205 | 73 | 1.81 | $28,478 | $12,028 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Short return visit (20+ min) | 156 | $15,757 | $76 |
| Return visit (30+ min) | 89 | $15,366 | $114 |
| New patient visit (45+ min) | 77 | $11,090 | $144 |
| New patient visit (30+ min) | 93 | $8,968 | $96 |
| Removal of fingernails or toenails, 6 or more nails | 83 | $6,144 | $39 |
| Removal of skin and tissue, 20.0 sq cm or less | 17 | $5,934 | $132 |
| Removal of noncancer thickened skin growth, 1 growth | 37 | $4,338 | $65 |
| Removal of noncancer thickened skin growth, 2-4 growths | 27 | $3,620 | $75 |
| Permanent removal fingernail or toenail | 11 | $1,789 | $163 |
| Removal of fingernails or toenails, 1-5 nails | 18 | $694 | $33 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 15 | $20 | None |
2022: 11 services
| Short return visit (20+ min) | 165 | $20,529 | $78 |
| New patient visit (30+ min) | 123 | $11,491 | $93 |
| Return visit (30+ min) | 59 | $10,327 | $116 |
| Removal of fingernails or toenails, 6 or more nails | 97 | $7,502 | $39 |
| New patient visit (45+ min) | 50 | $7,090 | $142 |
| Removal of skin and tissue, 20.0 sq cm or less | 21 | $6,371 | $118 |
| Permanent removal fingernail or toenail | 15 | $2,550 | $134 |
| Removal of noncancer thickened skin growth, 1 growth | 27 | $2,508 | $66 |
| Removal of noncancer thickened skin growth, 2-4 growths | 18 | $2,164 | $80 |
| Injection into tendon or ligament | 18 | $1,207 | $52 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 31 | $37 | None |
2021: 12 services
| Short return visit (20+ min) | 202 | $26,787 | $80 |
| Removal of fingernails or toenails, 6 or more nails | 215 | $15,371 | $41 |
| New patient visit (30+ min) | 149 | $14,192 | $95 |
| Removal of skin and tissue, 20.0 sq cm or less | 27 | $10,103 | $133 |
| Return visit (30+ min) | 24 | $3,595 | $124 |
| Removal of noncancer thickened skin growth, 2-4 growths | 20 | $2,536 | $77 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $2,176 | $181 |
| Permanent removal fingernail or toenail | 13 | $2,107 | $132 |
| New patient visit (45+ min) | 13 | $2,061 | $159 |
| Removal of noncancer thickened skin growth, 1 growth | 18 | $1,248 | $66 |
| Removal of fingernails or toenails, 1-5 nails | 12 | $431 | $33 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $19 | None |
2020: 7 services
| Short return visit (20+ min) | 125 | $14,181 | $67 |
| New patient visit (30+ min) | 141 | $12,327 | $87 |
| Removal of skin and tissue, 20.0 sq cm or less | 20 | $10,815 | $123 |
| Removal of fingernails or toenails, 6 or more nails | 119 | $8,813 | $39 |
| Removal of noncancer thickened skin growth, 1 growth | 28 | $1,349 | $45 |
| Removal of noncancer thickened skin growth, 2-4 growths | 14 | $1,319 | $66 |
| Removal of fingernails or toenails, 1-5 nails | 15 | $461 | $27 |
2019: 6 services
| Removal of skin and tissue, 20.0 sq cm or less | 19 | $11,370 | $116 |
| New patient visit (30+ min) | 77 | $7,327 | $95 |
| Short return visit (20+ min) | 62 | $6,179 | $69 |
| Removal of fingernails or toenails, 6 or more nails | 64 | $3,056 | $44 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,756 | $172 |
| Removal of noncancer thickened skin growth, 1 growth | 16 | $977 | $54 |
2018: 4 services
| Removal of skin and tissue, 20.0 sq cm or less | 25 | $8,719 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,601 | $180 |
| Short return visit (20+ min) | 17 | $1,847 | $68 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 17 | $1,073 | $35 |
2017: 15 services
| Removal of fingernails or toenails, 6 or more nails | 189 | $15,062 | $35 |
| Short return visit (20+ min) | 104 | $11,920 | $58 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 13 | $7,019 | $132 |
| Removal of skin and tissue, 20.0 sq cm or less | 21 | $5,088 | $102 |
| New patient visit (30+ min) | 54 | $4,437 | $82 |
| Removal of noncancer thickened skin growth, 2-4 growths | 38 | $2,802 | $46 |
| Removal of skin and tissue, 20.0 sq cm or less | 20 | $2,568 | $47 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,329 | $166 |
| Permanent removal fingernail or toenail | 13 | $2,137 | $112 |
| Short return visit | 44 | $2,044 | $30 |
| Removal of noncancer thickened skin growth, 1 growth | 30 | $1,851 | $34 |
| Short return visit (20+ min) | 13 | $1,516 | $43 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $932 | $33 |
| X-ray of foot, minimum of 3 views | 26 | $779 | $23 |
| X-ray of ankle, minimum of 3 views | 11 | $235 | $20 |
2016: 5 services
| Removal of fingernails or toenails, 6 or more nails | 75 | $2,954 | $39 |
| Short return visit (20+ min) | 33 | $2,276 | $63 |
| New patient visit (30+ min) | 19 | $1,736 | $91 |
| Removal of noncancer thickened skin growth, 2-4 growths | 14 | $723 | $52 |
| Short return visit | 18 | $721 | $38 |
Drugs they prescribed that Part D paid
$48,243
Pharmacies billed $48,243 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (11 of 441) in 2024. At or below the middle of the specialty; the typical podiatry clinician is at 5%.
402 generic and 39 brand-name prescriptions · $48,243 in drug cost · 33 antibiotic prescriptions to 22 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jublia | 25 | $35,972 | $1,439 |
| Ciclopirox | 105 | $2,925 | $28 |
| Econazole Nitrate | 45 | $1,740 | $39 |
| Clotrimazole | 47 | $1,405 | $30 |
| Ketoconazole | 37 | $1,227 | $33 |
See all 10 drugs
| Jublia | 25 | $35,972 | $1,439 |
| Ciclopirox | 105 | $2,925 | $28 |
| Econazole Nitrate | 45 | $1,740 | $39 |
| Clotrimazole | 47 | $1,405 | $30 |
| Ketoconazole | 37 | $1,227 | $33 |
| Gabapentin | 42 | $369 | $9 |
| Terbinafine | 26 | $300 | $12 |
| Naproxen | 16 | $166 | $10 |
| Ibuprofen | 14 | $137 | $10 |
| Clindamycin | 11 | $112 | $10 |
Year by year
| 2024 | 441 | 195 | 3% (11) | 9% | $48,243 |
| 2023 | 456 | 197 | 5% (24) | 5% | $27,536 |
| 2022 | 390 | 173 | None | 6% | $32,533 |
| 2021 | 442 | 189 | 7% (31) | 4% | $24,780 |
| 2020 | 450 | 171 | 5% (24) | None | $11,582 |
| 2019 | 137 | 69 | None | None | $4,089 |
| 2018 | 272 | 115 | 7% (20) | 6% | $25,756 |
| 2017 | 1,096 | 332 | 1% (12) | 7% | $374,548 |
| 2016 | 108 | 74 | 0% (0) | 14% | $28,261 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Clotrimazole | 126 | $4,649 | $37 |
| Econazole Nitrate | 27 | $2,707 | $100 |
| Ketoconazole | 51 | $2,437 | $48 |
| Ciclopirox | 55 | $2,199 | $40 |
| Terbinafine | 25 | $525 | $21 |
| Gabapentin | 32 | $328 | $10 |
| Clindamycin | 12 | $178 | $15 |
| Naproxen | 14 | $167 | $12 |
| Hydrocodone-Acetaminophen | 17 | $121 | $7 |
2022: 7 drugs
| Jublia | 12 | $21,549 | $1,796 |
| Clotrimazole | 142 | $5,518 | $39 |
| Ketoconazole | 38 | $1,635 | $43 |
| Diclofenac | 12 | $507 | $42 |
| Terbinafine | 27 | $352 | $13 |
| Naproxen | 27 | $319 | $12 |
| Gabapentin | 28 | $76 | $3 |
2021: 10 drugs
| Clotrimazole | 87 | $3,775 | $43 |
| Ketoconazole | 62 | $2,582 | $42 |
| Ciclopirox | 79 | $2,510 | $32 |
| Diclofenac | 17 | $692 | $41 |
| Terbinafine | 29 | $445 | $15 |
| Clotrimazole-Betamethasone | 12 | $396 | $33 |
| Naproxen | 18 | $170 | $9 |
| Hydrocodone-Acetaminophen | 22 | $149 | $7 |
| Cephalexin | 15 | $116 | $8 |
| Gabapentin | 18 | $103 | $6 |
2020: 9 drugs
| Ciclopirox | 106 | $2,865 | $27 |
| Clotrimazole-Betamethasone | 74 | $2,587 | $35 |
| Ketoconazole | 50 | $1,690 | $34 |
| Diclofenac | 57 | $1,358 | $24 |
| Clotrimazole | 26 | $1,258 | $48 |
| Clindamycin | 32 | $270 | $8 |
| Naproxen | 11 | $132 | $12 |
| Hydrocodone-Acetaminophen | 14 | $113 | $8 |
| Gabapentin | 19 | $109 | $6 |
2019: 4 drugs
| Ciclopirox | 36 | $1,141 | $32 |
| Clotrimazole | 20 | $1,032 | $52 |
| Clotrimazole-Betamethasone | 20 | $533 | $27 |
| Diclofenac | 13 | $396 | $30 |
2018: 4 drugs
| Ketoconazole | 73 | $5,206 | $71 |
| Clotrimazole | 74 | $3,323 | $45 |
| Diclofenac | 13 | $1,761 | $135 |
| Ciclopirox | 37 | $912 | $25 |
2017: 16 drugs
| Calcipotriene | 46 | $94,948 | $2,064 |
| Calcipotriene-Betamethasone Dp | 34 | $77,455 | $2,278 |
| Amantadine | 41 | $29,827 | $727 |
| Diclofenac | 103 | $24,997 | $243 |
| Lidocaine | 31 | $23,609 | $762 |
| Clotrimazole | 301 | $13,981 | $46 |
| Ketoconazole | 199 | $13,709 | $69 |
| Econazole Nitrate | 39 | $9,685 | $248 |
| Voltaren | 24 | $6,071 | $253 |
| Ciclopirox | 56 | $1,516 | $27 |
| Clotrimazole-Betamethasone | 22 | $837 | $38 |
| Gabapentin | 28 | $186 | $7 |
| Amoxicillin-Clavulanate Potass | 17 | $177 | $10 |
| Terbinafine | 11 | $110 | $10 |
| Hydrocodone-Acetaminophen | 11 | $88 | $8 |
| Meloxicam | 15 | $63 | $4 |
2016: 2 drugs
| Lidocaine | 11 | $12,018 | $1,093 |
| Clotrimazole | 54 | $2,333 | $43 |
Money from drug and device companies
$309 in 2025
| 2025 | 5 | 5 | None | $309 |
| 2024 | 1 | 1 | None | $15 |
| 2023 | 2 | 3 | None | $56 |
| 2022 | 1 | 2 | None | $77 |
| 2021 | 2 | 3 | None | $1,243 |
| 2020 | 2 | 2 | None | $45 |
| 2019 | 8 | 21 | None | $1,928 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Smith+Nephew | Collagenase Santyl | $125 | 1 payment
|
| Paragon 28 | Portfolio | $110 | 1 payment
|
| Stryker | Augment Injectable | $30 | 1 payment
|
| Treace Medical Concepts | Lapiplasty System 1 | $24 | 1 payment
|
| Orthofix Medical | Physio-Stim | $20 | 1 payment
|
See all 5 published payments
| Smith+Nephew | Meals · 2025-12-17 | Collagenase Santyl | $125 |
| Orthofix Medical | Meals · 2025-09-20 | Physio-Stim | $20 |
| Stryker | Meals · 2025-09-03 | Augment Injectable | $30 |
| Paragon 28 | Meals · 2025-08-15 | Portfolio | $110 |
| Treace Medical Concepts | Meals · 2025-05-30 | Lapiplasty System 1 | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $15
| Stryker | Augment Injectable | $15 | 1 payment
|
2023: $56
| Treace Medical Concepts | Lapiplasty System | $35 | 2 payments
|
| Orthofix Medical | Physio-Stim | $22 | 1 payment
|
2022: $77
| Treace Medical Concepts | Lapiplasty System | $77 | 2 payments
|
2021: $1,243
| Evolution Surgical | None | $1,200 | 1 payment
|
| Smith+Nephew | Memofix | $43 | 2 payments
|
2020: $45
| Integra LifeSciences | Amnioexcel | $30 | 1 payment
|
| Stryker | Asnis | $15 | 1 payment
|
2019: $1,928
| Wright Medical Technology | Salvation | $796 | 9 payments
|
| Stryker | Variax | $770 | 6 payments
|
| Organogenesis | Apligraf | $109 | 1 payment
|
| Evolution Surgical | None | $106 | 1 payment
|
| Smith+Nephew | Grafix Pl Prime | $97 | 1 payment
|
| Acell | None | $24 | 1 payment
|
| Musculoskeletal Transplant Foundation | None | $15 | 1 payment
|
| Arthrosurface | Hemicap Mtp Resurfacing | $13 | 1 payment
|
Professional record
- NPI
- 1235472754
- Licence
- CA EL5217
- Trained
- California School of Podiatric Medicine, 2013
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 213ES0103X (213ES0103X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2013-04-03
- NPI last updated
- 2019-09-03
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 350 John Muir Pkwy Ste 140, Brentwood, CA, 94513 · 1701 E Cesar E Chavez Ave, Los Angeles, CA, 90033 · 12 Camino Encinas, Orinda, CA, 94563